Teligent Pharma, Inc. recalls Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by:…
- Recall date
- June 22, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0690-2021
- FDA classification
- Class III
- Brand / firm
- Teligent Pharma, Inc.
- Sold / distributed
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,
Get recall alerts
Free email alert whenever Teligent Pharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teligent Pharma, Inc.